You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Gastric bypass surgery is more efficacious than intensive lifestyle and medical treatment for type 2 diabetes remission
  1. Kristina H Lewis1,
  2. David Arterburn2
  1. 1Kaiser Center for Health Research, Atlanta, Georgia, USA;
  2. 2Group Health Research Institute, Seattle, Washington, USA
  1. Correspondence to: Dr David Arterburn
    , Group Health Research Institute, 1730 Minor Ave, Suite 1600 Seattle, WA 98108, USA; arterburn.d{at}ghc.org

https://doi.org/10.1136/eb-2013-101580

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidaemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013;309:2240–49.OpenUrlCrossRefPubMedWeb of Science

    Context

    Despite numerous medication and lifestyle treatment options, just over half of patients with type 2 diabetes mellitus (T2DM) achieve a glycated haemoglobin (HbA1c) of <7%.1 Roux-en-y gastric bypass surgery (RYGB) has traditionally been reserved for treating severe obesity, but there is growing interest in using this and other bariatric procedures to treat T2DM in less obese patients.2 ,3 There have been few rigorous studies comparing RYGB against best available non-surgical treatment for control of T2DM and comorbid conditions.

    Methods

    Ikramuddin and colleagues conducted a …

    View Full Text

    Footnotes

    • Competing interests None.